IDALLO study: A retrospective multicenter study of the SFGM-TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1-mutated AML after allogeneic hematopoietic cell transplantation.

Caillet, Adrien; Simonet-Boissard, Marion; Forcade, Edouard; Robin, Marie; Rubio, Marie-Thérèse; Couturier, Marie-Anne; Srour, Micha; Maillard, Natacha; Devillier, Raynier; Huynh, Anne; Bourhis, Jean-Henri; Simand, Célestine; Chantepie, Sylvain; Boisson, Cyril; Kroemer, Marie; Deconinck, Eric; Berceanu, Ana

IDALLO study: A retrospective multicenter study of the SFGM-TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1-mutated AML after allogeneic hematopoietic cell transplantation.

Caillet, Adrien; Simonet-Boissard, Marion; Forcade, Edouard; Robin, Marie; Rubio, Marie-Thérèse; Couturier, Marie-Anne; Srour, Micha; Maillard, Natacha; Devillier, Raynier; Huynh, Anne; Bourhis, Jean-Henri; Simand, Célestine; Chantepie, Sylvain; Boisson, Cyril; Kroemer, Marie; Deconinck, Eric; Berceanu, Ana.

Afiliación

Caillet A; Hematology Department, Hôpital Jean Minjoz CHU Besançon Besançon France.
Simonet-Boissard M; Hematology Department, Hôpital Jean Minjoz CHU Besançon Besançon France.
Forcade E; Hematology Department, Hôpital Haut-Lévêque CHU Bordeaux Bordeaux France.
Robin M; Hematology Department Hôpital Saint-Louis Paris France.
Rubio MT; Hematology Department, Hôpital Brabois CHU Nancy Nancy France.
Couturier MA; Hematology Department CHU Brest Brest France.
Srour M; Hematology Department, CHU de Lille University of Lille Lille France.
Maillard N; Hematology Department CHU Poitiers Poitiers France.
Devillier R; Hematology Department Institut Paoli-Calmettes Marseille France.
Huynh A; Hematology Department IUCT Oncopole Toulouse France.
Bourhis JH; Hematology Department Institut Gustave Roussy Villejuif France.
Simand C; Hematology Department, ICANS CHU Strasbourg Strasbourg France.
Chantepie S; Hematology Department CHU Caen Caen France.
Boisson C; Methodological and Quality of Life in Oncology Unit, University Hospital of Besançon, Franche-Comté University, INSERM, Etablissement Français du Sang Bourgogne Franche-Comté, UMR 1098 Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique Besançon France.
Kroemer M; Pharmacy Department, INSERM, Etablissement Français du Sang, Bourgogne Franche Comté, UMR 1098 Interactions Hôte-Greffon-Tumeur/Inginérie Cellulaire et Génique Besançon France.
Deconinck E; Hematology Department Centre Hospitalier Universitaire de Besancon Besançon France.
Berceanu A; Hematology Department, Hôpital Jean Minjoz CHU Besançon Besançon France.

Hemasphere ; 8(3): e44, 2024 Mar.

Article en En | MEDLINE | ID: mdl-38469458

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Hemasphere Año: 2024 Tipo del documento: Article